Business Wire

CA-ANDERSEN-GLOBAL

31.1.2024 18:16:28 CET | Business Wire | Pressemeddelelse

Del
Andersen udvider værdiansættelseskapaciteten i Latinamerika med tilføjelser i Argentina, Chile, Colombia og Mexico

Andersen, den hurtigst voksende uafhængige, multidisciplinære serviceorganisation i verden, har udvidet sin værdiansættelseskapacitet og sit team med tilføjelsen af samarbejdsvirksomheder i Argentina, Chile, Colombia og Mexico. Bekendtgørelsen finder sted i forlængelse af lanceringen af Andersens globale værdiansættelsespraksis og tilføjelsen af værdiansættelseskapaciteter i Brasilien sidste år. Disse tilføjelser styrker organisationens hurtigt voksende platform i regionen, som allerede udbyder skattemæssig og juridisk dækning i mere end 18 lande i hele Latinamerika.

De nye firmaer, der slutter sig til Andersens platform i Latinamerika, inkluderer:

  • First Capital Group (Argentina) – First Capital Group har base i Buenos Aires og er et team af finansfolk med over 30 års erfaring i at levere forretningsmæssige og finansielle løsninger, herunder værdiansættelsesydelser.
  • Valoriza (Chile) – Med kontorer i Santiago og Miami er Valoriza et uafhængigt firma, der leverer grundige og indsigtsfulde værdiansættelser med fokus på værdiansættelse af virksomheder og M&A for det mellemstore marked.
  • Valuaciones de Chile (Chile) – Valuaciones de Chile har base i Santiago og leverer uafhængige værdiansættelsestjenester med fokus på fast ejendom, aktiver samt maskiner og udstyr.
  • Confianza (Colombia) – Confianza holder til i Bogota, har specialiseret sig i værdiansættelser af maskiner og udstyr og giver kunder i Latinamerika omfattende støtte til deres finansielle aktiviteter.
  • Giron Valuation Services (Mexico) – Giron Valuation Services (GVS), der opererer fra Estado de México, er et team af fagfolk med stor erfaring i at levere værdiansættelser af virksomheder og økonomisk rådgivning til både lokale og globale kunder.

"Værdiansættelse er et vigtigt vækstområde for Andersen, og man kan forvente at se os udvide vores globale værdiansættelsespraksis hastigt på andre vigtige markeder i Latinamerika og globalt," siger Mark L. Vorsatz, global bestyrelsesformand og administrerende direktør for Andersen.

"Vi er stolte over at arbejde sammen med disse firmaer, når vi udvider vores globale værdiansættelsesservice i Latinamerika," tilføjer Sid Luckenbach, administrerende direktør for Andersens globale værdiansættelsespraksis. "Disse nye firmaer er et stærkt kulturelt match for Andersen og deler vores forpligtelse på uafhængighed, problemfri kundeservice, forvaltning og ekspertise."

Andersens globale værdiansættelsesteam samarbejder med virksomheder, fonde, velhavende privatpersoner og familiekontorer om værdiansættelse af virksomheder, materielle og immaterielle aktiver og komplekse værdipapirer med henblik på skat, finansiel rapportering og transaktionsrådgivning. Andersens kunder spænder over en række brancher med forskellige værdiansættelsesbehov på globalt plan.

"Latinamerika er fortsat et spændende vækstmarked for os," siger Leonardo Mesquita, Andersens regionale administrerende direktør for Latinamerika. "Vores kunder kræver i stigende grad uafhængige værdiansættelser i hele regionen, og vi ser frem til at opfylde deres værdiansættelsesbehov som ét firma."

Andersens globale værdiansættelsespraksis er repræsenteret i mere end 25 lande i Nordamerika, Europa, Latinamerika, Mellemøsten og Asien.

Om Andersen :

Andersen Global er en international sammenslutning af juridisk adskilte og uafhængige medlemsvirksomheder, der består af skatteeksperter og -jurister i hele verden. Andersen Global, der blev etableret i 2013 af den amerikanske medlemsvirksomhed Andersen Tax LLC, har nu mere end 15.000 eksperter i hele verden og en tilstedeværelse på over 425 lokaliteter gennem sine medlems- og samarbejdsvirksomheder.

Originalsprogsudgaven af denne bekendtgørelse er den officielle, autoriserede version. Oversættelserne er kun tænkt som en hjælp og bør sammenholdes med kildesprogsteksten, der som den eneste er juridisk bindende.

For at se dette indhold fra cts.businesswire.com, så skal du give din accept på toppen af denne side.

Se kildeudgaven på businesswire.com: https://www.businesswire.com/news/home/20240130606657/da/

Information om Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Følg pressemeddelelser fra Business Wire

Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.

Flere pressemeddelelser fra Business Wire

Quaise Energy Selected for Up to $25 Million in U.S. Department of Energy Support to Advance World's First Commercial Superhot Geothermal Power Plant22.9.2026 15:30:00 CEST | Press release

Quaise's Project Obsidian, a commercial-scale superhot Enhanced Geothermal System (EGS), selected to receive federal funding as part of $99 million DOE effort to advance geothermal energy development across the United States Supports completion of the first well triplet at Project Obsidian, targeting more than 25 megawatts of gross electric power Project team includes Pacific Northwest National Laboratory, Lawrence Berkeley National Laboratory and Oregon State University Quaise Energy, a leading developer of utility-scale superhot geothermal energy, today announced that it has been selected by the U.S. Department of Energy (DOE) for up to $25 million in funding under the Next-Generation Geothermal Field Tests and Geothermal Resource Characterization and Confirmation funding opportunity. The support brings the U.S. closer to commercializing superhot Enhanced Geothermal Systems — technology that could unlock firm, clean power from hot rock beneath virtually any geography in the country.

Takeda Highlights Late-Stage Oncology Pipeline Progress and Solid Tumor Portfolio Research, Led by Late-Breaking Phase 3 Arcotatug Tavatecan (TAK-921) Data, at ESMO 202622.9.2026 15:30:00 CEST | Press release

Late-Breaking Abstract to Feature New Data from First Phase 3 Registrational Study of Arcotatug Tavatecan in Previously Treated Advanced Gastric CancerTAK-928 Presentations Reinforce Potential in Patients with Immunotherapy-Resistant Non-Small Cell Lung Cancer (NSCLC) and Previously Untreated NSCLCTakeda Continues to Progress Clinical Development of Arcotatug Tavatecan and TAK-928; New Non-Squamous NSCLC Sub-Trial Added to Global Phase 3 MarsLight-11 Study Evaluating TAK-928 vs. Docetaxel Monotherapy Takeda(TSE:4502/NYSE:TAK)announced that new data from its oncology pipeline and portfolio will be presented at the European Society for Medical Oncology (ESMO) Congress, taking place October 23-27, 2026, in Madrid, Spain. Key data will include a late-breaking abstract on arcotatug tavatecan (TAK-921; Innovent R&D code: IBI343*) and two presentations on TAK-928 (Innovent R&D code: IBI363*). Clinical and real-world analyses of ALUNBRIG® (brigatinib) and FRUZAQLA® (fruquintinib) will also be

From CSR to Public Health Impact: How Colgate Bright Smiles, Bright Futures® is Driving Behavior Change for the Next Billion Children and Their Families22.9.2026 15:00:00 CEST | Press release

Colgate-Palmolive builds on its legacy of oral health, publishing an impact evaluation, evolving its health education tools rooted in behavior change, and scaling its global health partnerships. Colgate-Palmolive, the worldwide leader in oral care, announced a strategic evolution in its flagship oral health education program, Colgate Bright Smiles, Bright Futures® (BSBF), reflecting the Company’s commitment to global public health. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260922129016/en/ Launched in 1991, the program has reached over two billion children and their families across more than 100 countries, demonstrating how private-sector commitment designed to support communities, can become a powerful force for public health, driving healthier behaviors and positive outcomes at scale. From health education curriculum and school programming to mobile dental vans and free oral health screenings, BSBF helps children and

Citi Wealth’s 2026 Global Family Office Report Reveals Clients Are Shifting Their Focus Towards Public Equities While Becoming More Deliberate and Resilient Amid Uncertainty22.9.2026 14:30:00 CEST | Press release

Public equities have re-emerged as the primary destination for incremental capital Private markets remain a strategic pillar of family office portfolios Artificial intelligence is moving from experimentation toward implementation Cross-border complexity is rising as families become increasingly international Leadership succession and next-generation preparedness are now immediate priorities rather than distant considerations Watch Citi Wealth’s Global Family Office leadership discuss the report’s findings here. Citi Wealth today released its 2026 Global Family Office Report, offering an inside perspective into the thinking and behaviors of the world’s most sophisticated investors. The report was compiled by Citi Wealth’s Global Family Office Group, which works with more than 1,900 family offices worldwide. Conducted in June and July 2026, the survey sheds light on how over 350 family offices in more than 40 countries are navigating new complexities in an era defined by uncertainty. Tod

Incyte Data at the European Academy of Dermatology and Venereology (EADV) Congress Underscore the Breadth of Incyte’s Inflammation and Autoimmunity Portfolio22.9.2026 14:30:00 CEST | Press release

Incyte (Nasdaq:INCY) today announced that data from across its Inflammation and Autoimmunity (IAI) portfolio will be presented at the European Academy of Dermatology and Venereology (EADV) 2026, held September 30 - October 3, 2026, in Vienna, Austria. "The breadth of research being presented at EADV 2026 highlights the strength of our Inflammation and Autoimmunity portfolio," said Pablo J. Cagnoni, M.D., President, Incyte and Global Head of Research and Development. "Data presentations in hidradenitis suppurativa, atopic dermatitis and prurigo nodularis demonstrate our commitment to advancing innovation across immune-mediated skin diseases and deepening our understanding of the patient experience." Details on key Incyte data presentations at EADV include: Oral Presentations Atopic Dermatitis Atopic Dermatitis and Life Course Disruption: Evidence From a Multidimensional International Survey (TOPiQAL) (Session: Free Communication 1: Atopic dermatitis/Eczema. Thursday, October 1, 2:50-3:0

I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter samt finde vores kontaktoplysninger.

Besøg vores nyhedsrum
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye